A transformative $200 million gift to NYU Long Island School of Medicine will ensure generations of medical students continue to receive a tuition-free, top-quality education focused on primary care.
Atezolizumab by F. Hoffmann-La Roche for Urethral Cancer: Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug